About GlySens
GlySens is a company based in San Diego (United States) founded in 1997. GlySens has raised $47 million across 9 funding rounds from investors including HHS, McNair Interests and Fayez Sarofim. The company has 29 employees as of December 31, 2022. GlySens offers products and services including Breakfast Menu, Salads, and Coneys. GlySens operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.
- Headquarter San Diego, United States
- Employees 29 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
- Legal Name Glysens Incorporated
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$47 M (USD)
in 9 rounds
-
Latest Funding Round
$15 M (USD), Unspecified
Jun 12, 2020
-
Investors
HHS
& 4 more
-
Employee Count
29
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GlySens
GlySens offers a comprehensive portfolio of products and services, including Breakfast Menu, Salads, and Coneys.
Provides various breakfast items for morning dining
Offers fresh salad options as healthy meal choices
Specializes in coney-style hot dogs and related items
People of GlySens
Unlock access to complete
Funding Insights of GlySens
GlySens has successfully raised a total of $47M across 9 strategic funding rounds. The most recent funding activity was a Unspecified round of $15 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GlySens
GlySens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, McNair Interests and Fayez Sarofim.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services are offered by McNair Interests in Houston.
|
Locked | Locked | Locked | |
|
Global private equity investments are managed from Houston.
|
Locked | Locked | Locked | |
|
Research and health information on diabetes and kidney diseases are provided by NIDDK.
|
Locked | Locked | Locked |
Investor details for GlySens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GlySens
Investment portfolio details for GlySens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GlySens
Detailed financials for GlySens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glysens Comparisons
Peer comparison for GlySens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GlySens
GlySens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
|
| Locked | Locked | Locked |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| Locked | Locked | Locked |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
Detailed competitors of GlySens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glysens
Complete news archive for GlySens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GlySens
GlySens was founded in 1997 and raised its 1st funding round 10 years after it was founded.
GlySens is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
William Markle is the current CEO of GlySens.
GlySens is a funded company, having raised a total of $47M across 9 funding rounds to date.
As of Dec 31, 2022, the latest employee count at GlySens is 29.
GlySens Incorporated was founded in 1997 in San Diego, United States, within the biomedical technology sector. Implantable sensors for continuous glucose monitoring are produced, offering real-time blood glucose readings, historical data charts, adjustable alerts for hypo- and hyperglycemic events, and onboard storage. Wireless connections to external receivers are enabled, with preclinical trials indicating sensor lifetimes of up to 18 months. Operations focus on diabetes management solutions.
GlySens's top competitors include Dexcom, Senseonics and One Drop.
GlySens offers Breakfast Menu, Salads, and Coneys.
GlySens has 5 investors. Key investors include HHS, McNair Interests, Fayez Sarofim, National Institute of Diabetes and Digestive and Kidney Diseases, and West Health.